COSTANZO, ANTONIO
 Distribuzione geografica
Continente #
AS - Asia 270
NA - Nord America 171
EU - Europa 26
SA - Sud America 19
AF - Africa 1
Totale 487
Nazione #
US - Stati Uniti d'America 164
SG - Singapore 143
CN - Cina 60
VN - Vietnam 41
BR - Brasile 11
IT - Italia 11
HK - Hong Kong 7
GB - Regno Unito 6
CA - Canada 3
ID - Indonesia 3
AR - Argentina 2
EC - Ecuador 2
MX - Messico 2
PK - Pakistan 2
PL - Polonia 2
PY - Paraguay 2
SE - Svezia 2
AZ - Azerbaigian 1
BD - Bangladesh 1
ES - Italia 1
FR - Francia 1
GT - Guatemala 1
IE - Irlanda 1
IN - India 1
JP - Giappone 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LT - Lituania 1
MY - Malesia 1
NI - Nicaragua 1
NL - Olanda 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
QA - Qatar 1
SA - Arabia Saudita 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 487
Città #
Singapore 66
San Jose 62
Ashburn 16
Ho Chi Minh City 12
Beijing 11
Boardman 7
Council Bluffs 6
Hanoi 6
Hong Kong 6
New York 5
Pisa 5
Santa Clara 4
Los Angeles 3
Orem 3
Phoenix 3
Poplar 3
Atlanta 2
Bến Tre 2
Da Nang 2
Dallas 2
Denver 2
Elk Grove Village 2
Mexico City 2
Porto Alegre 2
Salt Lake City 2
Warsaw 2
Amsterdam 1
Anápolis 1
Baku 1
Bauru 1
Bellevue 1
Belo Horizonte 1
Biên Hòa 1
Buffalo 1
Calgary 1
Cambridge 1
Campinas 1
Can Tho 1
Chelles 1
Chicago 1
Ciudad del Este 1
Cleveland 1
Cuiabá 1
Da Lat 1
Doha 1
Dolores 1
Dublin 1
Dūrā 1
Fortaleza 1
Fresno 1
Glasgow 1
Greenwood Village 1
Guayaquil 1
Gujranwala 1
Ha Long 1
Holley 1
Hudson 1
Hòa Bình 1
Kampong Loyang 1
Kuala Lumpur 1
Kuwait City 1
Lagomar 1
Lahore 1
Lanús 1
Le Roy 1
London 1
Lấp Vò 1
Managua 1
Manchester 1
Manila 1
Maracaibo 1
Matupá 1
Medan 1
Medina 1
Milan 1
Miles City 1
Montreal 1
Mumbai 1
Muscat 1
Ninh Bình 1
North Haven 1
Paterna 1
Phnom Penh 1
Pouso Alegre 1
Queens 1
Quito 1
Quận Bình Thạnh 1
Redondo Beach 1
Reynoldsburg 1
Rio de Janeiro 1
Saint Albans 1
Saint Paul 1
San Lorenzo 1
San Marcellino 1
Senago 1
Sfax 1
Shanghai 1
Tashkent 1
Tokyo 1
Tân An 1
Totale 312
Nome #
Guselkumab Retention, Effectiveness, and Safety in Psoriasis: A 260-Week Real-World Multicenter Retrospective Study Exploring the Role of Concomitant PsA–IL PSO (Italian Landscape Psoriasis) 51
Safety of interleukin inhibitors in patients with plaque psoriasis and history of neoplasms: a multicenter retrospective study – IL PSO (Italian landscape psoriasis) 51
Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations 41
Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations 41
Optimizing Tildrakizumab Dosing in Psoriasis: A 52-Week Multicenter Retrospective Study Comparing 100 mg and 200 mg—IL PSO (Italian Landscape Psoriasis) 40
Real‐life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104‐week multicenter retrospective study – IL PSO (ITALIAN LANDSCAPE PSORIASIS) 38
The risk of candidiasis during treatment with bimekizumab for the management of plaque psoriasis: a 16-week multicentre real-world experience – IL PSO (Italian Landscape Psoriasis) 29
Anti-IL-17/23 Drugs for the Treatment of Moderate-to-Severe Hidradenitis Suppurativa in Patients With Concomitant Psoriasis: A Multicenter Retrospective Study 29
Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study—IL PSO (Italian Landscape Psoriasis) 25
Real‐life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52‐week multicentre retrospective study—IL PSO (Italian landscape psoriasis) 25
Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study—IL PSO (ITALIAN LANDSCAPE PSORIASIS) 23
Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study 22
Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study – IL PSO (Italian landscape psoriasis) 21
Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses – IL PSO (Italian landscape psoriasis) 20
Bimekizumab for the Treatment of Plaque Psoriasis With Involvement of Genitalia: A 16-Week Multicenter Real-World Experience—IL PSO (Italian Landscape Psoriasis) 18
Brodalumab for the treatment of plaque psoriasis in a real-life setting: a 3 years multicenter retrospective study—IL PSO (Italian landscape psoriasis) 16
Real life long‐term efficacy and safety of ixekizumab in moderate‐to‐severe psoriasis: A 192 weeks multicentric retrospective study— IL PSO ( Italian landscape psoriasis) 14
Totale 504
Categoria #
all - tutte 1.157
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.157


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/2026487 0 0 0 25 123 66 67 34 39 99 28 6
2026/202717 17 0 0 0 0 0 0 0 0 0 0 0
Totale 504